Log In
Print
BCIQ
Print
Print this Print this
 

Campath-1H, alemtuzumab (Lemtrada, MabCampath, Campath)

Also known as: MabCampath-1H alemtuzumab (LDP-03)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHumanized mAb against CD52
Molecular Target CD52
Mechanism of ActionBinds CD52
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today